Iloperidone crystalline formulation
CILO522E2101
Phase 2 small_molecule completed
Quick answer
Iloperidone crystalline formulation for Schizophrenia is a Phase 2 program (small_molecule) at Vanda Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals Netherlands B.V.
- Indication
- Schizophrenia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed